Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Age‐specific progression of nigrostriatal dysfunction in Parkinson's disease
Raúl de la Fuente‐Fernández, Michael Schulzer, Lisa Kuramoto, et al.
Annals of Neurology (2010) Vol. 69, Iss. 5, pp. 803-810
Closed Access | Times Cited: 212

Showing 1-25 of 212 citing articles:

MDS research criteria for prodromal Parkinson's disease
Daniela Berg, Ronald B. Postuma, Charles H. Adler, et al.
Movement Disorders (2015) Vol. 30, Iss. 12, pp. 1600-1611
Open Access | Times Cited: 1131
Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
Michael Erkkinen, Mee-Ohk Kim, Michael D. Geschwind
Cold Spring Harbor Perspectives in Biology (2017) Vol. 10, Iss. 4, pp. a033118-a033118
Open Access | Times Cited: 928
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
José Á. Obeso, María Stamelou, Christopher G. Goetz, et al.
Movement Disorders (2017) Vol. 32, Iss. 9, pp. 1264-1310
Open Access | Times Cited: 719
Parkinson Disease Subtypes
Mary Ann Thenganatt, Joseph Jankovic
JAMA Neurology (2014) Vol. 71, Iss. 4, pp. 499-499
Closed Access | Times Cited: 459
Axon degeneration in Parkinson's disease
Robert E. Burke, Karen L. O’Malley
Experimental Neurology (2012) Vol. 246, pp. 72-83
Open Access | Times Cited: 444
Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
K. A. Jellinger
Movement Disorders (2011) Vol. 27, Iss. 1, pp. 8-30
Closed Access | Times Cited: 428
Ageing, Cellular Senescence and Neurodegenerative Disease
Marios Kritsilis, Sophia V. Rizou, Paraskevi N. Koutsoudaki, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 2937-2937
Open Access | Times Cited: 346
Advances in markers of prodromal Parkinson disease
Ronald B. Postuma, Daniela Berg
Nature Reviews Neurology (2016) Vol. 12, Iss. 11, pp. 622-634
Closed Access | Times Cited: 331
The neurobiological basis of cognitive impairment in Parkinson's disease
Glenda M. Halliday, James B. Leverenz, Jay S. Schneider, et al.
Movement Disorders (2014) Vol. 29, Iss. 5, pp. 634-650
Open Access | Times Cited: 327
How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder
Ronald B. Postuma, Anthony E. Lang, Jean Gagnon, et al.
Brain (2012) Vol. 135, Iss. 6, pp. 1860-1870
Open Access | Times Cited: 314
Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study
Álex Iranzo, Francesc Valldeoriola, Francisco Lomeña, et al.
The Lancet Neurology (2011) Vol. 10, Iss. 9, pp. 797-805
Closed Access | Times Cited: 300
The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
Roberto Cilia, Albert Akpalu, Fred Stephen Sarfo, et al.
Brain (2014) Vol. 137, Iss. 10, pp. 2731-2742
Open Access | Times Cited: 289
The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort
Konrad Szewczyk‐Królikowski, Paul Tomlinson, Kannan Nithi, et al.
Parkinsonism & Related Disorders (2013) Vol. 20, Iss. 1, pp. 99-105
Open Access | Times Cited: 260
The Concept of Prodromal Parkinson’s Disease
Philipp Mahlknecht, Klaus Seppi, Werner Poewe
Journal of Parkinson s Disease (2015) Vol. 5, Iss. 4, pp. 681-697
Open Access | Times Cited: 243
Neuroimaging in Parkinson disease: from research setting to clinical practice
Marios Politis
Nature Reviews Neurology (2014) Vol. 10, Iss. 12, pp. 708-722
Closed Access | Times Cited: 224
Gait analysis with wearables predicts conversion to Parkinson disease
Silvia Del Din, Morad Elshehabi, Brook Galna, et al.
Annals of Neurology (2019) Vol. 86, Iss. 3, pp. 357-367
Open Access | Times Cited: 179
Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder
Álex Iranzo, Joan Santamaría, Francesc Valldeoriola, et al.
Annals of Neurology (2017) Vol. 82, Iss. 3, pp. 419-428
Closed Access | Times Cited: 176
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Javier Blesa, Guglielmo Foffani, Benjamin Dehay, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 115-128
Closed Access | Times Cited: 157
Parkinson's disease, aging and adult neurogenesis: Wnt/β‐catenin signalling as the key to unlock the mystery of endogenous brain repair
Bianca Marchetti, Cataldo Tirolo, Francesca L’Episcopo, et al.
Aging Cell (2020) Vol. 19, Iss. 3
Open Access | Times Cited: 142
Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson Disease
Trina Mitchell, Stéphane Lehéricy, Shannon Chiu, et al.
JAMA Neurology (2021) Vol. 78, Iss. 10, pp. 1262-1262
Open Access | Times Cited: 141
The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease
Emma Biondetti, Mathieu Santin, Romain Valabrègue, et al.
Brain (2021) Vol. 144, Iss. 10, pp. 3114-3125
Open Access | Times Cited: 116
Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease
Jee‐Young Lee, Antonio Martín‐Bastida, Ane Murueta‐Goyena, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 4, pp. 203-220
Closed Access | Times Cited: 81
Premotor Parkinson's disease: Concepts and definitions
Andrew Siderowf, Anthony E. Lang
Movement Disorders (2012) Vol. 27, Iss. 5, pp. 608-616
Open Access | Times Cited: 169
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease
Christopher L. German, Michelle Baladi, Lisa M. McFadden, et al.
Pharmacological Reviews (2015) Vol. 67, Iss. 4, pp. 1005-1024
Open Access | Times Cited: 166
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Ioannis U. Isaias, Paula Trujillo, Paul Summers, et al.
Frontiers in Aging Neuroscience (2016) Vol. 8
Open Access | Times Cited: 160
Page 1 - Next Page

Scroll to top